PRIMAXIN IV
NDC 0006-3516, imipenem and cilastatin sodium, injection, powder, for solution, from Merck Sharp & Dohme LLC.
- Product NDC
- 0006-3516
- Status
- Listed
- Labeler
- Merck Sharp & Dohme LLC
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA050587
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0006-3516 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IMIPENEM500 mg/100mL
- CILASTATIN SODIUM500 mg/100mL
Pharmacologic classes
Carbapenems [CS]; Dipeptidase Inhibitors [MoA]; Penem Antibacterial [EPC]; Renal Dehydropeptidase Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0006-3516-59 | 00006351659 | 25 VIAL, SINGLE-DOSE in 1 TRAY (0006-3516-59) / 100 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/f41d8abd-7792-4918-1b93-bd83ea01955eMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0006-3516
Use it
Look up 0006-3516 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0006-3516 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0006-3516. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.